(Q34295018)

1 August 2017

Peripheral muscle weakness in RASopathies (English)

1 reference

peripheral muscle weakness

1 August 2017

1 reference

1 reference

David A Stevenson

1

1 reference

1 August 2017

Shawn Allen

2

1 reference

1 August 2017

William E Tidyman

3

1 reference

1 August 2017

John C Carey

4

1 reference

1 August 2017

David H Viskochil

5

1 reference

1 August 2017

Austin Stevens

6

1 reference

1 August 2017

Heather Hanson

7

1 reference

1 August 2017

Xiaoming Sheng

8

1 reference

1 August 2017

Brandi A Thompson

9

1 reference

1 August 2017

Megumi J Okumura

10

1 reference

1 August 2017

Kent Reinker

11

1 reference

1 August 2017

Barbara Johnson

12

1 reference

1 August 2017

Katherine A Rauen

13

1 reference

1 August 2017

1 September 2012

1 reference

1 August 2017

1 reference

1 August 2017

46

1 reference

1 August 2017

3

1 reference

1 August 2017

394-399

1 reference

The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation

1 August 2017

1 reference

The musculoskeletal phenotype of the RASopathies

21 January 2018

1 reference

Motor proficiency in children with neurofibromatosis type 1

21 January 2018

1 reference

Lower extremity strength and hopping and jumping ground reaction forces in children with neurofibromatosis type 1

21 January 2018

1 reference

Skeletal muscle pathology in Costello and cardio-facio-cutaneous syndromes: developmental consequences of germline Ras/MAPK activation on myogenesis

21 January 2018

1 reference

Orthopaedic conditions in Ras/MAPK related disorders

21 January 2018

1 reference

Costello syndrome: orthopaedic manifestations and functional health

21 January 2018

1 reference

Myopathy caused by HRAS germline mutations: implications for disturbed myogenic differentiation in the presence of constitutive HRas activation

21 January 2018

1 reference

Neurofibromin (Nf1) is required for skeletal muscle development

21 January 2018

1 reference

The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2.

21 January 2018

1 reference

Spherical grip strength in children 3 to 6 years of age.

21 January 2018

1 reference

Life extension through neurofibromin mitochondrial regulation and antioxidant therapy for neurofibromatosis-1 in Drosophila melanogaster

21 January 2018

1 reference

21 January 2018

1 reference

Mitochondrial dysfunction and organic aciduria in five patients carrying mutations in the Ras-MAPK pathway.

21 January 2018

1 reference

Vitamin D status and muscle function in post-menarchal adolescent girls

21 January 2018

1 reference

Pediatric 25-hydroxyvitamin D concentrations in neurofibromatosis type 1

21 January 2018

1 reference

A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach

21 January 2018

1 reference

Bone resorption in syndromes of the Ras/MAPK pathway

21 January 2018

1 reference

Myopathology in patients with a Noonan phenotype

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MUS.23324

1 reference

1 August 2017

1 reference